Dr. Salman Punekar, MD
Claim this profileNYU Langone Medical Center
Studies Solid Tumors
Studies Cancer
14 reported clinical trials
19 drugs studied
Area of expertise
1Solid Tumors
Stage IV
Stage III
KRAS positive
2Cancer
Stage IV
Stage III
ARID1A positive
Affiliated Hospitals
Clinical Trials Salman Punekar, MD is currently running
EP0031
for Cancer
The aim of this study is to assess the safety, side effects and effectiveness of EP0031 in patients with advanced RET-altered malignancies
Recruiting1 award Phase 1 & 2
SIM1811-03
for Cutaneous T-Cell Lymphoma
This is a first in human, open-label, dose escalation and expansion Phase 1 study of SIM1811-03 in adult patients with advanced solid tumors and cutaneous T-cell lymphoma. SIM1811-03 is a first-in-class IgG1-based humanized anti-tumor necrosis factor type 2 receptor (TNFR2) monoclonal antibody for the treatment of malignant tumors.
Recruiting1 award Phase 1
More about Salman Punekar, MD
Clinical Trial Related5 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Salman Punekar, MD has experience with
- Ladarixin
- Sotorasib
- SIM0237
- A2B530
- AFNT-211
- Talimogene Laherparepvec
Breakdown of trials Salman Punekar, MD has run
Solid Tumors
Non-Small Cell Lung Cancer
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Salman Punekar, MD specialize in?
Salman Punekar, MD focuses on Solid Tumors and Cancer. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Stage III.
Is Salman Punekar, MD currently recruiting for clinical trials?
Yes, Salman Punekar, MD is currently recruiting for 10 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Salman Punekar, MD has studied deeply?
Yes, Salman Punekar, MD has studied treatments such as Ladarixin, Sotorasib, SIM0237.
What is the best way to schedule an appointment with Salman Punekar, MD?
Apply for one of the trials that Salman Punekar, MD is conducting.
What is the office address of Salman Punekar, MD?
The office of Salman Punekar, MD is located at: NYU Langone Medical Center, New York, New York 10016 United States. This is the address for their practice at the NYU Langone Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.